hotspot -WSS

hotspot

author：explore 2025-09-29 16:45:05 - browse：48

Jeremey Wyatt ActiGraph

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： FDA advisers vote against ALS treatment from BrainStorm

WSS

North Korean leader's powerful sister says warplanes repelled US spy plane

UPS workers' union leader explains what's at stake as strike edges closer

Researchers use wearables data and AI to predict preterm birth risk

Paxlovid should be available without a positive Covid test

Sen. Bill Cassidy on how to lower drug prices

California man arrested in connection with serial murders of Mexican strip club workers

leisure time

hotspot

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Why do women spend more than men on medical expenses?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Mindstrong's demise and the future of mental health care

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ionis has late

Walensky prepares to leave CDC — and Congress — behind

With fresh data, a dynamic duo powers Eli Lilly to new heights

Heart attack and stroke risk calculators need revising

What to know about a major upcoming Wegovy heart health study

leisure time

Menendez indictment could see pharma lose a key ally

Did you have Obamacare on your GOP debate bingo card?

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Covid vaccines: Private market messier than government rollout

Cigna to pay $172 million to settle Medicare Advantage fraud probe

hotspot

hotspot

focus

knowledge